Literature DB >> 27301940

Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.

Peter Birkeland1, Kate Gardner2, Rachel Kesse-Adu2, John Davies2, Jens Lauritsen2, Frantz Rom Poulsen2, Christos M Tolias2, Swee Lay Thein2.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial aneurysms and aneurysmal subarachnoid hemorrhage may occur more frequently in sickle-cell disease (SCD), and this could be related to the sickle genotype and moyamoya syndrome seen in SCD.
METHODS: Records from a total of 1002 patients with SCD attending 2 specialized adult hematologic services were retrospectively reviewed. We analyzed data of a cohort of 767 patients attending 1 SCD clinic between 2002 and 2013 and of 235 patients from the other clinic who have had neurovascular imaging between 2007 and 2014.
RESULTS: We identified 4 patients in the cohort who had an aneurysmal subarachnoid hemorrhage during 9063 patient-years. The highest incidence rate was seen among women in the age group 30 to 39 years with the hemoglobin SS (HbSS) genotype (440 per 100 000 patient-years). Unruptured intracranial aneurysms were found in 20 of the 324 patients, who had imaging data; the prevalence was significantly higher in patients with HbSS genotype compared with other sickle genotypes with the highest prevalence (15%) observed in women in the age group 30 to 39 years. Fifty-one HbSS patients had a moyamoya vasculopathy, but only 3 of these had concomitant intracranial aneurysms.
CONCLUSIONS: Intracranial aneurysms are common in HbSS SCD. There was also a trend toward more common occurrence of aneurysmal subarachnoid hemorrhage in HbSS; women in the age group 30 to 39 years were most at risk. There was no correlation between the occurrence of intracranial aneurysms and moyamoya syndrome.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  anemia, sickle cell; intracranial aneurysm; moyamoya disease; stroke; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2016        PMID: 27301940     DOI: 10.1161/STROKEAHA.116.012664

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

2.  Optimal disease management and health monitoring in adults with sickle cell disease.

Authors:  Jo Howard; Swee Lay Thein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  How I treat the older adult with sickle cell disease.

Authors:  Swee Lay Thein; Jo Howard
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

4.  Characteristics of Moyamoya Syndrome in Sickle-Cell Disease by Magnetic Resonance Angiography: An Adult-Cohort Study.

Authors:  Paul Kauv; Noémie Gaudré; Jérôme Hodel; Titien Tuilier; Anoosha Habibi; Catherine Oppenheim; Myriam Edjlali; Dominique Hervé; David Calvet; Pablo Bartolucci
Journal:  Front Neurol       Date:  2019-01-22       Impact factor: 4.003

5.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

6.  Characterizing Intracranial Hemodynamics in Sickle Cell Anemia: Impact of Patient-Specific Viscosity.

Authors:  Sara B Keller; Jacob M Bumpus; J Christopher Gatenby; Elizabeth Yang; Adetola A Kassim; Carlton Dampier; John C Gore; Amanda K W Buck
Journal:  Cardiovasc Eng Technol       Date:  2021-07-20       Impact factor: 2.305

7.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.